De Contactus |

R&THALF-YearlyReport:NetProfitIncreasedBy40.8%.RevenueOfSmartToiletsAndCoversIncreasedBy21.65%

Blog

R&T dimidium-annuam famam: Net lucrum augeri 40.8%. Vectigal Smart Toilets et Covers augeri 21.65%

R&T dimidium-annuam famam: Net lucrum augeri 40.8%. Vectigal Smart Toilets et Covers augeri 21.65%

Ad vesperas Aug 24, Xiamen R&T Sanitary Technology Co., Ltd. semi-anno ejus fama dimisit ad 2022. Renuntiatio ostendit quod R&Vectigal RMB901 decies centena millia primi consecuti sunt 2022, augmentum 12.11% annus-in-annus. Net lucrum ascribitur socios qui in comitatu enumerantur 83,424,400 Yuan, augmentum 40.8% annus-in-annus. Inter eos, intelligentes latrina et operimentum products effectum reditus de RMB 411 decies, augmentum 21.65% annus-in-annus.

Current renuntiationes tempusIdem tempus prioris anniAugere vel diminuere in current relatione period comparari cum eodem tempore prioris anni
Operating reditus (Yuan)900, 63& 099. 96803, 319, 911.6712. 11%
Net lucrum attribuendum sociis quae enumerantur societatis quaestus (Yuan)83, 424,429. 2059, 249,967. 9240. 80%
Ascribit socios electronicarum rete retiarii lucri de non-remissa lucra et damna (Yuan)75, 930,193. 8849, 867,702. 3452. 26%
Net cash flow ex operating actionibus vehicula (Yuan)157, 515, 475. 6063, 883,452. 60146. 57%
Basic earnings per share (Yuan / share)0.19960. 1442. 57%
Dilutus earnings per share (Yuan / share)0.19960. 1442. 57%
Segment reditus in rete bonorum4.62%2.91%1.71%
In fine huius tempus renuntiationesFinis prioris anniAugere vel diminuere in fine huius relationis tempus cum fine prioris anni
Summa bonorum (Yuan)2, 281,411,724. 362, 23& 933,160. 691.90%
Net bonorum adscribuntur socios enumerantur societatibus BONA (Yuan)1,796,215,346. 821,773,942,522.991.26%

 

Dolor latrina et operimentum products effectum reditus of 411 decies

Annos in annos incrementum est 21.65%

Net quaestus

In primo dimidium 2022, R&T foricas callidi est et negotia tegit fortiter crescere perseuerauit. Vectigal effectum fuit RMB 411 decies, augmentum 21.65% annus-in-annus. Negotium reputatus 45.64% societas totalis reditus operandi.

Insuper, financial fama ostendit quod R *&T specialitas in inquisitione et progressu, productio et venditio intelligentium sanitate products subsidiaria – Xiamen parum intelligentis technology Co. In 2022, in operating reditibus primum dimidium anni pervenit 275 Decies Yuan, et operating lucrum pervenit 14.48 Decies Yuan.

Company NameTurba TypePrincipale negotiumRegistered CapitalTotalis BONANet AssetsOperating reditusOperans ReditusNet lucrum
Xiamen Pavimentum Latrina Technology Co. ComitatusSubsidiary CompanyInvestigatio et progressus, processus, productio et venditio; Sanitary Ware, fingit, plastic products, rubber products, hardware supporting partes.600,000.0 0 Yuan18,965,11 5.512,139,507 .7165,047,20 9.185, 483, 647.395,483,647 .39
Xiamen One Point Intelligent Technology Co.SubsidiariesInvestigatio et progressus, productio et venditio prudentium ware sanitate products.300,000,0 00.00 Yuan615, 820, 462.81417,103,6 26.58274, 914, 468.4314, 484, 595.6411,775,09 7. 52
Xiamen aqua Drop elit Co.SubsidiaryInvestment in primaria, secundarium et tertiarium industries; investment consulting; operatio importare et exportare variarum commodorum et technologiarum.100,000,000.00 Yuan101,680,8 54.06101,502,2 42. 530.00563,385.4 0409,635.2 1
AQUATIZ INVESTMEN T PTE. LTDSubsidiariesActiones praetorii et praetorii regionalis; centralised procuratio officiorum et procuratio subsidiaria.4, 000, 000 .00 USD24,243,40 6.6324, 092, 140. 260.00165,225.0 9155,995.9 4

In annis, R&T augere collocationem suam in ware sanitate intelligente. Ut mane 2020, R&T terminabitur “Yangming Road latrina accessiones productio basis renovationis et expansionis project” ac implemented “annua productio facultatem of * 1.2 decies centena millia intelligentes balneo products productio basi constructione project” per subsidiaria societatis totum possessores, Xiamen One Point Intelligent Technology Co. Ut in fine periodi, cumulativo investment de project perventum est 83.67 Decies Yuan, et progressus consilii 16.97%. Exspectatur ut R&T vectigal in portione ware sanitaria intelligente crescere perget postquam inceptum perfectum est et in operatione impositum.

Unitas: Yuan

Current renuntiationes tempusIdem tempus prioris anniAnnos in annos incremento / decrescentibus
MolesShare of operating reditusMolesShare of operating reditus
Totalis deducuntur Operating900,63& 099. 96100%803,319,911.67100%12.11%
per Industry
Industry900,63& 099. 96100. 00%803,319,911.67100. 00%12.11%
per Productum
Aquae lacus et accessiones36& 380,403. 9340. 90%36& 634,489. 8945. 89%-0.07%
Dolor latrina et Cover Plates411,057,941.7945. 64%337,905,473.0742. 06%21.65%
Co-Level INCILE Products79, 943, 507. 07& 88%66,86& 105. 728.32%19.55%
alii38, 598, 013. 404. 29%2& 124,409. 353.50%37. 24%
Scrap, fingit pro sale etc.2, 658, 233. 770. 30%1,787,433. 640.22%48.72%
per regionem
Extra Sina304,699, 785. 8733. 83%263,790,799.3132. 84%15. 51%
Inbound595,93& 314. 0966. 17%539,529,112. 3667.16%10.46%

Praeter ware sanitate intelligentes, R&T's principalia producta etiam piscinas aquae accessionesque productorum includunt, tum in eodem tabulato products ratio INCILE. In primo dimidium 2022, piscinas aquarum et fortia mercatus vectigalia $368 decies. Hoc repraesentatur a 0.07% annos in annos decrescit et pro 40.9% de reditus totalis societatis. Vectigalia consecuta negotia ad homogenea INCILE systematis productorum erat $79,943,500, augmentum 19.55% annus-in-annus.

R&T gerit negotia domestica et remote. In primo dimidium 2022, vectigalia duorum negotiorum erant NT$ DXCVI decies centena et NT$ CCCV decies centena millia;, CULTUS 66.17% et 33.83%, respective. Uterque plus quam augetur 10%.

 

Net lucrum augetur 40.8% annus-in-annus

Gross lucrum margo principalis negotii auctus cum priore anno

Secundum earnings, In prima media 2022 R&T incrementi emolumenti et vectigal, cum rete lucrum ascribendum socios enumerantur societatis attingentes 83,424,400 Yuan, augmentum 40.8% annus-in-annus. Lucrum rete ascribendum sociis societatis inscripti post lucra non-remissa et damna facta RMB 75,930,200, augmentum 52.26% annus-in-annus, quod erat notabile incrementum.

In margine crassa termini, In prima media 2022, in crassa margine sui principalis negotii incrementum consecutus est, reaching 25.29%, in 2.08% eodem tempore prioris anni. Inter eos, crassa lucrum margine aquae piscinae et accessiones negotii augentur 2.7% comparari ad priorem annum. Dolor latrina et operculum negotium habuit maximum incrementum, reaching 4.58%.

Unitas: Yuan

O*perating reditusSumptibus operatingMarginal crassaOperating reditus in anno priore anno in annos incremento / diminutionemOperating sumptibus comparari cum priore anno Year-in-annus incremento / decrescentibusCrassa lucrum margo in anno prioris crescat vel decrescat per idem tempus
per Industry
Industry900,63& 099.96672,822,608.0525.29%12.11%9. 08%2. 08%
Sub-products
Aquae lacus et accessiones36& 380,403.93274, 705, 782.7825.43%-0. 07%-3. 56%2. 70%
Dolor latrina et Covers411,057,941.79313, 38& 396.6123.76%21.65%14. 75%4. 58%
per regionem
Extra Sina304,699, 785.87222,692, 775.3026.91%15. 51%14.12%0. 89%
Inbound595,93& 314.09450,129,832.7524.47%10. 46%6.75%2. 62%

In primo dimidium 2022, multis R *&T expensis signanter mutatum est. Inter eos, expensis constat numerus -25.27 decies, decrementum 812.8% comparari ad priorem annum, maxime propter impulsum commutatione rate mutationes. Reditus tributum inpensa pervenit RMB 13,292,100, augmentum 124.66% annus-in-annus. Et hoc maxime propter augmentum lucri. R . eius&D expensae summae RMB35,581,400 ., augmentum 55.75% annus-in-annus, propter auctus investment in R *&D in domum products. Memorabile est quod in mense Maio hoc anno, R&T addidi 1 novam obsidionem peregrinae in incepti nomine Xiamen Shui Ai Intelligent Domus Co. In investment est 20 Decies Yuan, et principale negotium eius est fabricare, investigationis et progressionem, et venditio de familia products, Sanitary Ware, etc.

Unitas: Yuan

Current renuntiationes tempusIdem tempus prioris anniAnnos in annos incremento / decrescentibusRatio mutationis
Operating reditus900, 638,099. 96803,319,911.6712. 11%
Sumptibus operating672, 822,60& 05616,803,175.159.08%
Vendere expensis60,614,944. 504& 242, 286. 6925. 65%
Administrativus expensas62,708,530. 6650, 726, 445. 6823. 62%
Sumptibus oeconomicis-25, 267,738. 853, 544, 872. 11-812. 80%Effectus commutatione rate mutationes
Reditus tributum inpensa13,292,111. 705,916, 580. 76124. 66%Prodest incrementum
R&D investment35,581,424. 7322,845, 299. 0155. 75%Societas domum products auxit R&D investment
Cash generatur ab operating actionibus Net fluxus ab operating actionibus157, 515,475. 6063,883, 452. 60146. 57%Crescere in rate de solutione recuperationis societatis effectus
Cash generatae ex circumsedere actiones Net cash flow ex circumsedere actionibus-42, 493,971.67-34, 067,117.92-24. 74%
Nummi de financing actiones Net cash fluit ex financing actiones-66, 030,490. 25-63,646,344. 93-3. 75%
Net cash et cash adumbrari adauge70, 550,577. 95-34,917,498. 83302. 05%Crescere in rate de solutione recuperationis societatis effectus

Insuper, R&T revelatum est societatem bene notam in industria in segmento partium aquarum rutilantium, comprehendo ROCA, INAX, KOHLER, Vexillum, Arrox, Bolina et alii artifices domestici et externi noti medii et summi finis notae sanitariae mercaturae bonae et stabiles necessitudines cooperantes cum societatis statuerunt..

R&T in prima medietate peragi 2022 clara fuit. Secundum reditus, quamvis 12.1% incremento non aequo, maxime rara est in contextu repercussionis pestilentiae ac spirae deorsum rerum venalium. Contra, multi versos domestici viderunt vectigal declinationem primo dimidium anni. Aliquot societates vel minui per plus quam 10%. Ad merita gradu, R&T dimidium rete quaestus primi gradus temporis eiusdem periodi in . recuperavit et excessit 2019 ante pestilentiam, et incrementum usque ad expand. Hoc bonum corporatum profitability.

In August 25, et securitates turba dedit R *&T a “buy” rating, his de causis: Primum, intelligentes latrina perficientur pulchrum est. In manu satis sunt ordines. Secundus, Q2 quaestus signanter emendatus est, et bonam potestatem expensis. Manifesto, hoc quoque mercatus capitalis aestimatio obiectiva R&T in prima medietate anni.

Prev:

deinde:

Vivamus Chat
Aliquam nuntium